drugset / Trial / NCT00254735

Quetiapine Augmentation in Severe Obsessive Compulsive Disorder

NCT00254735

Phase 3 Completed 44 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate the efficacy of quetiapine or placebo added to baseline treatment of SSRI/clomipramine for the treatment of OCD in adult subjects.

Timeline

Start
2002-04
Primary completion
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule
Background Clomipramine Small molecule